ceronapril has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutler, NR; Markowitz, J; Mickelson, W; Repetti, S; Sramek, JJ; Sudilovsky, A; Veroff, AE; Wardle, T | 1 |
| Barnes, NM; Cheng, CH; Costall, B; Naylor, RJ; Williams, TJ; Wischik, CM | 1 |
1 trial(s) available for ceronapril and Alzheimer Disease
| Article | Year |
|---|---|
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Organophosphorus Compounds; Pilot Projects; Proline | 1993 |
1 other study(ies) available for ceronapril and Alzheimer Disease
| Article | Year |
|---|---|
Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cerebellum; Female; Frontal Lobe; Humans; Male; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Temporal Lobe; Tritium | 1991 |